Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
immune-type problems after COVID vaccination; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNE SYSTEM DISORDER (immune-type problems after COVID vaccination) in an adult female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNE SYSTEM DISORDER (immune-type problems after COVID vaccination). At the time of the report, IMMUNE SYSTEM DISORDER (immune-type problems after COVID vaccination) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No concomitant medication was reported. Medical History (vaccines within the past 4 weeks, medical conditions) was reported unknown. The patient had immune-type problems after COVID vaccination. It was unknown if the patient experienced any additional symptoms/events. This case created for 3rd female patient out of 3 female patients. This case was linked to US-MODERNATX, INC.-MOD-2025-788968 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-788968:Patient 3 of 3